ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: A longitudinal ecological study

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Tomlinson, Laurie A ^a   Abel, Gary A ^b   Chaudhry, Afzal N ^c   Tomson, Charles R ^d   Wilkinson, Ian B ^a   Roland, Martin O ^b   Payne, Rupert A ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE KIDNEY FAILURE; ARTICLE; GENERAL PRACTICE; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; NATIONAL HEALTH SERVICE; PREDICTION; PRESCRIPTION; UNITED KINGDOM;

ACUTE KIDNEY INJURY; AGE FACTORS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENGLAND; FAMILY PRACTICE; FEMALE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; KIDNEY; LONGITUDINAL STUDIES; MALE; PEPTIDYL-DIPEPTIDASE A; PHYSICIAN'S PRACTICE PATTERNS; RECEPTOR, ANGIOTENSIN, TYPE 2; SEX FACTORS; STATE MEDICINE; TIME FACTORS;

EID: 84892376726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078465     Document Type: Article

References (30)

1. Wang HE, Muntner P, Chertow GM, Warnock DG (2012) Acute Kidney Injury and Mortality in Hospitalized Patients. Am J Nephrol 35: 349-355.
2. Abraham KA, Thompson EB, Bodger K, Pearson M (2012) Inequalities in outcomes of acute kidney injury in England. QJM.
3. Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, et al. (2007) Community-based incidence of acute renal failure. Kidney Int 72: 208-212.
4. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370.
5. Rifkin DE, Coca SG, Kalantar-Zadeh K (2012) Does AKI truly lead to CKD? J Am Soc Nephrol 23: 979-984.
6. Bellomo R, Kellum JA, Ronco C (2012) Acute kidney injury. Lancet 380: 756-766.
7. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S (2013) Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 346: e8525.
8. Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, et al. (2012) Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database. Fundam Clin Pharmacol.
9. Loboz KK, Shenfield GM (2005) Drug combinations and impaired renal function - the 'triple whammy'. Br J Clin Pharmacol 59: 239-243.
10. Plataki M, Kashani K, Cabello-Garza J, Maldonado F, Kashyap R, et al. (2011) Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol 6: 1744-1751.
11. Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, et al. (2008) Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 3: 1266-1273.
12. Adhiyaman V, Asghar M, Oke A, White AD, Shah IU (2001) Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. J R Soc Med 94: 512-514.
13. Rim MY, Ro H, Kang WC, Kim AJ, Park H, et al. (2012) The effect of Renin-Angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am J Kidney Dis 60: 576-582.
14. National Institute for Health and Clinical Excellence. Chronic kidney disease quality standard (2011) Available: http://publications.nice.org.uk/ chronic-kidney-disease-quality-standard-qs5/quality-statement-7-acute-illness. Accessed2013 February 25.
15. Wheeler DC, Becker GJ (2013) Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int 83: 377-383.
16. National Health Service. The Information Centre. Prescription Cost Analysis, England (2011) Available: http://www.ic.nhs.uk/catalogue/PUB05807/ pres-cost-anal-eng-2011-tab.zip Accessed 25 February 2013.
17. Smets HL, De Haes JF, De Swaef A, Jorens PG, Verpooten GA (2008) Exposure of the elderly to potential nephrotoxic drug combinations in Belgium. Pharmacoepidemiol Drug Saf 17: 1014-1019.
18. National Health Service Prescription Services. Available: http://www.nhsbsa.nhs.uk/3230.aspx
19. Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press http://www.medicinescomplete.com Accessed 2012 May 25.
20. Roberts SJ, Harris CM (1993) Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England. BMJ 307: 485-488.
21. National Health Service. The Information Centre. Hospital Episode Statistics. Available: http://www.hesonline.nhs.uk
22. World Health Organisation. International Classification of Diseases 10th Edition (1990) Available: http://www.who.int/classifications/icd/en/ Accessed 2012 May 25.
23. Tomlinson LA, Riding AM, Payne RA, Abel GA, Tomson CR, et al. (2013) The accuracy of diagnostic coding for acute kidney injury in England - a single centre study. BMC Nephrol 14: 58.
24. National Health Service. The Information Centre. Quality and Outcomes Framework. Online GP practice results database. Available http://www.qof.ic. nhs.uk/ Accessed 2011 October 26.
25. Huerta C, Castellsague J, Varas-Lorenzo C, Garcia Rodriguez LA (2005) Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 45: 531-539.
26. Vlasschaert ME, Bejaimal SA, Hackam DG, Quinn R, Cuerden MS, et al. (2010) Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis 57: 29-43.
27. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, et al. (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380: 37-43.
28. Brody H, Light DW (2011) The inverse benefit law: how drug marketing undermines patient safety and public health. Am J Public Health 101: 399-404.
29. World Health Organisation. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings (2010) Available: http://whqlibdoc.who.int/publications/2010/9789241598996-eng.pdf Accessed 2013 February 25.
30. Okunola O, Akinsola A, Ayodele O (2012) Kidney diseases in Africa: aetiological considerations, peculiarities and burden. Afr J Med Med Sci 41: 119-133.